BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36587987)

  • 1. Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.
    Diringer MC; Coliat P; Mathieu C; Laurent N; Mura C; Banerjee M; Zhu C; Grabowska A; Ritchie A; Clarke P; Bernard A; Vit C; Burckel H; Noel G; Harvey P; Pivot X; Detappe A
    Small; 2023 Mar; 19(12):e2205961. PubMed ID: 36587987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
    Gainer JL; Sheehan JP; Larner JM; Jones DR
    J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.
    Sheehan J; Ionescu A; Pouratian N; Hamilton DK; Schlesinger D; Oskouian RJ; Sansur C
    J Neurosurg; 2008 May; 108(5):972-8. PubMed ID: 18447715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Anti-hypoxia Potentials of Trans-sodium Crocetinate in Hypoxiarelated Diseases: A Review.
    Klunko NS; Achmad H; Abdullah TM; Mohammed S; Saha I; Salim KS; Obaid RF; Romero-Parra RM; Al-Hasnawi SS; Al-Janabi WH; Farhood B
    Curr Radiopharm; 2024; 17(1):30-37. PubMed ID: 37877507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crocetin and related oxygen diffusion-enhancing compounds: Review of chemical synthesis, pharmacology, clinical development, and novel therapeutic applications.
    Shah HM; Jain AS; Joshi SV; Kharkar PS
    Drug Dev Res; 2021 Nov; 82(7):883-895. PubMed ID: 33817811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of trans sodium crocetinate on brain tumor oxygenation. Laboratory investigation.
    Sheehan J; Sherman J; Cifarelli C; Jagannathan J; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2009 Aug; 111(2):226-9. PubMed ID: 19326986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor.
    Sheehan JP; Popp B; Monteith S; Toulmin S; Tomlinson J; Martin J; Cifarelli CP; Lee DH; Park DM
    J Neurosurg; 2011 Oct; 115(4):749-53. PubMed ID: 21682571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.
    Wang Y; Yoshimura R; Manabe H; Schretter C; Clarke R; Cai Y; Fitzgerald M; Lee KS
    Brain Res; 2014 Oct; 1583():245-54. PubMed ID: 25128603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.
    Dings RP; Loren M; Heun H; McNiel E; Griffioen AW; Mayo KH; Griffin RJ
    Clin Cancer Res; 2007 Jun; 13(11):3395-402. PubMed ID: 17545548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-sodium crocetinate for treating hypoxia/ischemia.
    Gainer JL
    Expert Opin Investig Drugs; 2008 Jun; 17(6):917-24. PubMed ID: 18491992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.
    Mertes PM; Collange O; Coliat P; Banerjee M; Diringer MC; Roche A; Delabranche X; Chaban V; Voegelin M; Bernard A; Sartori V; Laurent N; Velten M; Dhindsa N; Defuria J; Kim G; Xu ZH; Theodorou M; Huang ZR; Khalifa K; Geng B; Niyikiza C; Moyo V; Gizzi P; Villa P; Detappe A; Pivot X
    J Control Release; 2021 Aug; 336():252-261. PubMed ID: 34175365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.
    Manabe H; Okonkwo DO; Gainer JL; Clarke RH; Lee KS
    J Neurosurg; 2010 Oct; 113(4):802-9. PubMed ID: 19961314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H
    Song X; Xu J; Liang C; Chao Y; Jin Q; Wang C; Chen M; Liu Z
    Nano Lett; 2018 Oct; 18(10):6360-6368. PubMed ID: 30247918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.
    Okamoto S; Shiga T; Yasuda K; Watanabe S; Hirata K; Nishijima KI; Magota K; Kasai K; Onimaru R; Tuchiya K; Kuge Y; Shirato H; Tamaki N
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2147-2154. PubMed ID: 27251644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.
    Hu F; Vishwanath K; Salama JK; Erkanli A; Peterson B; Oleson JR; Lee WT; Brizel DM; Ramanujam N; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):462-469. PubMed ID: 27598811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice.
    Deng J; Xiong L; Zuo Z
    J Neurosci Res; 2015 Apr; 93(4):615-22. PubMed ID: 25491171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perihematomal Cellular Injury Is Reduced by Trans-sodium Crocetinate in a Model of Intracerebral Hemorrhage.
    Wang Y; Schretter C; Clarke R; Lee KS
    Mol Neurobiol; 2015 Oct; 52(2):985-9. PubMed ID: 26050085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.